Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2082 |  MESO Mesoblast Limited - American Depositary Shares | 13.74 USD | -3.85% | -3.10% | -3.17% | +31.99% | 1.76 B USD | ||
| 2087 |  VIR Vir Biotechnology, Inc. - Common Stock | 10.08 USD | -1.66% | +4.24% | +16.94% | +68.56% | 1.70 B USD | ||
| 2103 |  AAPG Ascentage Pharma Group International - American Depository Shar | 18.18 USD | -2.68% | -1.14% | +6.07% | -27.28% | 1.70 B USD | ||
| 2112 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 36.52 USD | -1.46% | +2.73% | +22.43% | +92.21% | 1.66 B USD | ||
| 2118 |  IMCR Immunocore Holdings plc - American Depositary Shares | 32.95 USD | -1.35% | +3.52% | +16.97% | -1.58% | 1.68 B USD | ||
| 2133 |  GHRS GH Research PLC - Ordinary Shares | 26.23 USD | -2.45% | -2.42% | +28.33% | +85.24% | 1.63 B USD | ||
| 2141 |  INVA Innoviva, Inc. - Common Stock | 22.37 USD | +0.54% | -0.18% | -0.71% | +25.53% | 1.65 B USD | ||
| 2146 |  ABSI Absci Corporation - Common Stock | 10.45 USD | -7.77% | -7.36% | +55.74% | +289.93% | 1.63 B USD | ||
| 2147 |  SEPN Septerna, Inc. - Common Stock | 35.90 USD | +0.20% | +5.50% | +16.98% | +63.11% | 1.62 B USD | ||
| 2152 |  FTRE Fortrea Holdings Inc. - Common Stock | 17.10 USD | -2.17% | -4.26% | +0.59% | +254.04% | 1.62 B USD | ||
| 2179 |  AVBP ArriVent BioPharma, Inc. - Common Stock | 33.00 USD | -3.45% | -4.84% | +6.31% | +60.12% | 1.54 B USD | ||
| 2184 |  NVAX Novavax, Inc. - Common Stock | 9.29 USD | -1.80% | -2.21% | +6.17% | +29.75% | 1.53 B USD | ||
| 2187 |  XERS Xeris Biopharma Holdings, Inc. - Common Stock | 8.53 USD | -4.59% | +4.28% | +36.48% | +74.80% | 1.47 B USD | ||
| 2203 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 5.70 USD | -3.72% | -8.80% | +12.43% | +103.57% | 1.47 B USD | ||
| 2220 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 95.97 USD | -4.74% | -0.55% | +5.46% | +19.10% | 1.41 B USD | ||
| 2232 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 18.77 USD | -1.98% | -3.35% | +2.62% | +96.34% | 1.38 B USD | ||
| 2237 |  IMTX Immatics N.V. - Ordinary Shares | 9.87 USD | -3.80% | -0.30% | +5.00% | -4.64% | 1.32 B USD | ||
| 2259 |  MGTX MeiraGTx Holdings plc - Ordinary Shares | 13.95 USD | -4.84% | +6.49% | +53.30% | +59.43% | 1.29 B USD | ||
| 2273 |  ARDX Ardelyx, Inc. - Common Stock | 5.34 USD | -0.74% | +1.71% | -5.49% | +18.93% | 1.32 B USD | ||
| 2277 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 15.79 USD | +1.02% | +2.87% | +40.48% | +297.73% | 1.33 B USD |
Notizie Biotechnology Stocks
BofA conferma il rating su Beam Therapeutics dopo il lodo arbitrale
Perché il titolo Beam Therapeutics sta scendendo oggi?
Perché il titolo Prime Medicine è in forte rialzo oggi?
Il titolo di Incyte raggiunge il massimo di 52 settimane a 118,77 USD
Il titolo di Prime Medicine sale dopo la vittoria nell’arbitrato contro Beam
Nurix Therapeutics: focus sull’impatto dell’accordo con Roche
Il titolo azionario di Edgewise Therapeutics raggiunge il massimo storico a 43,96 USD
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
 TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
 PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
 ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |